These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Garcés C; García LE Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150 [TBL] [Abstract][Full Text] [Related]
52. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Brixen KT; Christensen PM; Ejersted C; Langdahl BL Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497 [TBL] [Abstract][Full Text] [Related]
54. Drugs for postmenopausal osteoporosis. Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621 [No Abstract] [Full Text] [Related]
55. [Evaluation of the percentage of increased spongy bone in experimental osteoporosis treated with synthetic anabolic agents]. Carrozzo M; Pallante R; Lo Sasso F; D'Amore M Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):501-5. PubMed ID: 6612200 [TBL] [Abstract][Full Text] [Related]
56. [Effects of anabolic hormones on experimental osteoporosis]. Oizumi C Nihon Seikeigeka Gakkai Zasshi; 1966 Jun; 40(3):269-83. PubMed ID: 4961034 [No Abstract] [Full Text] [Related]
57. Anabolic steroids in corticosteroid-induced osteoporosis. Adami S; Rossini M Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456 [TBL] [Abstract][Full Text] [Related]